|
[1]
|
The Value of Excipients and the Required Understanding of the Biological System in Product Development: An Impactful Example of Curaderm, a Topical Skin Cancer …
|
|
International Journal of …,
2024 |
|
|
|
|
[2]
|
Gold Standard for Skin Cancer Treatment: Surgery (Mohs) or Microscopic Molecular-Cellular Therapy (Curaderm)?
|
|
Journal of Cancer Therapy,
2024 |
|
|
|
|
[3]
|
Unique Clinical Features of Curaderm when Treating Skin Cancers
|
|
Journal of Cancer Therapy,
2024 |
|
|
|
|
[4]
|
Holistic Approach in the Treatment of Actinic Keratosis: Benefits and Disadvantages of 5-Fluorouracil, Imiquimod, Diclofenac and Curaderm
|
|
International Journal of Clinical Medicine,
2023 |
|
|
|
|
[5]
|
Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival
|
|
2020 |
|
|
|
|
[6]
|
Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma
|
|
2020 |
|
|
|
|
[7]
|
First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm: A Case Report
|
|
2020 |
|
|
|
|
[8]
|
Outside the Box Cancer Therapies: Alternative Therapies That Treat and Prevent Cancer
|
|
2019 |
|
|
|
|
[9]
|
Dangerous plants in dermatology: Legal and controlled
|
|
Clinics in Dermatology,
2018 |
|
|
|
|
[10]
|
Outside the box cancer therapies : alternative therapies that treat and prevent cance
|
|
2018 |
|
|
|
|
[11]
|
Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
|
|
2017 |
|
|
|
|
[12]
|
A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity. Relevance to BEC and Solamargine, Example of a …
|
|
2015 |
|
|
|
|
[13]
|
A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical …
|
|
2015 |
|
|
|
|
[14]
|
A standardized plant extract containing a target compound is acceptable as a potent therapeutic entity: Relevance to BEC and solamargine, a topical clinical …
|
|
2015 |
|
|
|
|
[15]
|
Quantitative Sonography of Basal Cell Carcinoma
|
|
Ultrasound in medicine & biology,
2015 |
|
|
|
|
[16]
|
A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation Curaderm BEC5
|
|
Journal of Cancer Treatment and Research,
2015 |
|
|
|
|
[17]
|
Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
|
|
Journal of Cancer Therapy,
2015 |
|
|
|
|
[18]
|
A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis.
|
|
British Journal of Medicine and Medical Research,
2014 |
|
|
|
|
[19]
|
A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis
|
|
British Journal of Medicine and Medical Research,
2014 |
|
|
|
|
[20]
|
Statistics of envelope of ultrasonic backscatter from Basal Cell Carcinoma and Actinic Keratosis lesion
|
|
Ultrasonics Symposium (IUS), 2014 IEEE International,
2014 |
|
|
|
|
[21]
|
Topical CuradermBEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
|
|
International Journal of Clinical Medicine,
2013 |
|
|
|
|
[22]
|
Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
|
|
2013 |
|
|
|
|
[23]
|
Topical Curaderm BEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
|
|
2013 |
|
|
|